KalVista Pharmaceuticals (KALV) Stock Chart & Stock Price History → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free KALV Stock Alerts $12.19 +0.05 (+0.41%) (As of 05/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability KalVista Pharmaceuticals Stock Price Performance5 Day Performance+0.49%1 Month Performance+10.42%3 Month Performance-18.19%6 Month Performance+47.40%Year-To-Date Performance-0.49%1 Year Performance+27.78% Receive KALV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. KALV Stock Chart for Wednesday, May, 8, 2024 KALV Chart by TradingView KalVista Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$12.14$12.19+0.41%$12.28$11.97131,214 shs$514.30 million05/06/2024$12.13$12.14+0.08%$12.22$12.02193,066 shs$512.19 million05/03/2024$12.17$12.13-0.33%$12.48$11.96199,656 shs$511.77 million05/02/2024$12.18$12.17-0.08%$12.30$11.78571,496 shs$513.45 million05/01/2024$11.35$12.18+7.31%$12.52$11.35482,057 shs$513.87 million04/30/2024$11.01$11.35+3.09%$11.40$10.92321,782 shs$478.86 million Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$10.78$11.01+2.13%$11.19$10.88194,250 shs$464.51 million04/26/2024$10.49$10.78+2.76%$10.81$10.27241,417 shs$454.81 million04/25/2024$10.35$10.49+1.35%$10.52$10.11363,774 shs$442.57 million04/24/2024$11.21$10.35-7.67%$11.18$10.32482,316 shs$436.67 million04/23/2024$11.44$11.21-2.01%$11.71$11.19192,444 shs$472.95 million04/22/2024$11.57$11.44-1.12%$11.78$11.36289,249 shs$482.65 million04/19/2024$11.50$11.57+0.61%$11.78$11.27346,976 shs$488.14 million04/18/2024$11.65$11.50-1.29%$11.75$11.28408,653 shs$485.19 million04/17/2024$11.88$11.65-1.94%$11.94$11.65298,645 shs$491.51 million04/16/2024$11.74$11.88+1.19%$12.16$11.48489,733 shs$501.22 million04/15/2024$11.89$11.74-1.26%$12.01$11.50313,460 shs$495.31 million04/12/2024$12.10$11.89-1.74%$12.05$11.70237,891 shs$501.64 million04/11/2024$11.93$12.10+1.42%$12.26$11.71312,126 shs$510.48 million04/10/2024$11.81$11.93+1.02%$11.94$11.37554,624 shs$503.30 million04/09/2024$11.04$11.81+6.97%$11.85$11.02571,645 shs$498.26 million04/08/2024$11.09$11.04-0.45%$11.20$10.82210,204 shs$465.78 million04/05/2024$11.21$11.09-1.07%$11.38$10.97184,357 shs$467.89 million04/04/2024$11.26$11.21-0.44%$11.42$10.95500,277 shs$472.95 million04/03/2024$11.04$11.26+1.99%$11.34$10.81220,866 shs$475.06 million04/02/2024$11.40$11.04-3.16%$11.48$10.921.47 million shs$465.78 million04/01/2024$11.86$11.40-3.88%$11.79$11.03817,261 shs$480.97 million03/29/2024$11.86$11.86$12.46$10.922.15 million shs$500.37 million03/28/2024$11.07$11.86+7.14%$12.46$10.922.15 million shs$500.37 million03/27/2024$11.11$11.07-0.36%$11.41$10.97266,044 shs$467.04 million03/26/2024$11.13$11.11-0.18%$11.38$10.70520,288 shs$468.73 million03/25/2024$11.85$11.13-6.08%$11.84$11.04514,062 shs$499.93 million03/22/2024$12.15$11.85-2.47%$12.29$11.75270,704 shs$499.95 million03/21/2024$12.23$12.15-0.65%$12.70$12.07280,289 shs$512.61 million03/20/2024$11.84$12.23+3.29%$12.24$11.75446,784 shs$515.98 million03/19/2024$11.99$11.84-1.25%$12.38$11.65454,865 shs$499.53 million03/18/2024$11.93$11.99+0.50%$12.35$11.58560,270 shs$505.86 million03/15/2024$12.43$11.93-4.02%$12.56$11.87792,468 shs$503.33 million03/14/2024$12.49$12.43-0.48%$12.57$12.12458,750 shs$429.58 million03/13/2024$12.49$12.49$12.78$12.42408,314 shs$431.65 millionThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read03/12/2024$13.10$12.49-4.66%$13.07$12.31570,981 shs$431.65 million03/11/2024$14.36$13.10-8.77%$14.44$13.06664,015 shs$452.72 million03/08/2024$14.01$14.36+2.53%$14.52$13.771.22 million shs$496.28 million03/07/2024$14.38$14.01-2.61%$14.45$12.871.13 million shs$484.01 million03/06/2024$13.98$14.38+2.86%$14.62$14.05562,586 shs$496.97 million03/05/2024$14.03$13.98-0.36%$14.21$13.86434,316 shs$483.15 million03/04/2024$14.14$14.03-0.78%$14.27$13.86414,160 shs$484.88 million03/01/2024$13.65$14.14+3.59%$14.28$13.68501,947 shs$488.68 million02/29/2024$13.39$13.65+1.94%$13.81$13.43628,636 shs$471.74 million02/28/2024$14.62$13.39-8.41%$14.64$13.32960,533 shs$462.76 million02/27/2024$13.69$14.62+6.79%$14.80$13.821.04 million shs$505.27 million02/26/2024$12.58$13.69+8.82%$13.76$12.72964,478 shs$473.11 million02/23/2024$12.58$12.58$12.70$11.951.30 million shs$434.77 million02/22/2024$13.04$12.58-3.53%$13.11$12.481.27 million shs$434.77 million02/21/2024$13.80$13.04-5.51%$13.89$13.031.01 million shs$450.66 million02/20/2024$14.86$13.80-7.13%$14.78$13.611.38 million shs$476.93 million02/19/2024$14.86$14.86$15.00$14.311.21 million shs$513.56 million02/16/2024$14.76$14.86+0.68%$15.00$14.311.21 million shs$513.55 million02/15/2024$14.40$14.76+2.50%$16.88$14.657.34 million shs$510.11 million02/14/2024$14.85$14.40-3.03%$15.25$14.371.57 million shs$497.66 million02/13/2024$16.04$14.85-7.42%$16.13$13.264.46 million shs$513.22 million02/12/2024$16.00$16.04+0.25%$16.40$15.80453,491 shs$554.34 million02/09/2024$14.90$16.00+7.38%$16.24$15.30451,665 shs$552.96 million02/08/2024$14.45$14.90+3.11%$14.91$14.35444,992 shs$514.94 million02/07/2024$14.83$14.45-2.56%$14.98$14.31666,994 shs$499.39 million Related Companies: ABUS Stock Price Chart ALT Stock Price Chart STTK Stock Price Chart KRRO Stock Price Chart VERV Stock Price Chart ATXS Stock Price Chart APLT Stock Price Chart ANL Stock Price Chart FULC Stock Price Chart NGNE Stock Price Chart Receive KALV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KALV) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsShocking: One AI startup's revenue could surge 4,735%Manward PressAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.